Background
==========

Hydrogen sulfide (H~2~S) and nitric oxide (NO) have been recognized as endogenous signaling molecules, involved in a variety of homeostatic and disease processes. Although it is well-established that NO increases cGMP content of cells and tissues by activating soluble guanylyl cyclase (sGC), the ability of H~2~S to affect cyclic nucleotides levels has been controversial.

Results
=======

We have shown that H~2~S increases cGMP in both endothelial and smooth muscle cells. However, H~2~S does not activate sGC or alter NO-induced sGC activity. Interestingly, H~2~S inhibits phosphodiesterase (PDE) activity; although it reduces PDE activity of several PDE H~2~S is most effective and potent against PDE-5. IN line with the ability of H~2~S to increase cellular cGMP, we observed that exposure of cells to H~2~S leads to activation of cGMP-dependent protein kinase and VASP phosphorylation. As both NO and H~2~S promote angiogenesis and vasodilation we explored their interactions in the vessel wall in the context of these two biological processes. Inhibition of eNOS or PKG reduced the H~2~S-stumlated angiogenic properties of endothelial cells, as well as H~2~S--stimulated vasorelaxation, suggesting a prominent role for cGMP/PKG pathways in H~2~S signaling. On the other hand, silencing of the H~2~S-producing enzyme cystathionine-γ-lyase (CSE) reduced NO-stimulated cGMP accumulation, angiogenesis and smooth muscle relaxation, proving that NO requires H~2~S to manifest its effects. Finally, H~2~S-induced wound healing and angiogenesis in vivo was suppressed by pharmacological inhibition or genetic ablation of eNOS.

Conclusion
==========

Inhibition of the production of one gasotransmitter (NO or H~2~S) reduces the ability of the other to elevate cGMP and to trigger angiogenesis and vasodilation. These observations establish the existence of a positive, synergistic cross-talk between H~2~S and NO in vascular tissues.
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